Quoin Pharmaceuticals, Ltd.

Ownership Transactions Reported by 8 Insiders

Symbol: QNRX on Nasdaq
Industry: Pharmaceutical Preparations
Location: 23 Hata'as Street, Kfar Saba, Israel

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+104K	99.7%	$0.77	+$80.9K
Sells	1	-297	0.3%	$0.73	-$217
Net	+2	+104K	99.4%		+$80.6K

Quoin Pharmaceuticals, Ltd. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Michael Myers	Chief Executive Officer, Director	$37.7K	+$28.9K	+330%	Dec 9, 2024
Denise Carter	Chief Operating Officer, Director	$37.5K	+$28.7K	+328%	Dec 9, 2024
Gordon Dunn	Chief Financial Officer	$20.5K	+$23.2K		Dec 9, 2024
Dennis Langer	Director	$39.00	-$217	-84.8%	Dec 9, 2024
Anthony James Culverwell	Director				Dec 9, 2024
Natalie Leong	Director				Dec 9, 2024
Joseph Cooper	Director				Dec 9, 2024
Michael Sember	Director				Dec 9, 2024

Recent Insider Transactions by Companies or Individuals for Quoin Pharmaceuticals, Ltd.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.